bet36体育在线_bet36体育投注¥官网

图片
Zurück
bet36体育在线_bet36体育投注¥官网person
Prof. Dr. Dr.

Goran Kaluderovic

Funktionen

Professur für Anorganische Chemie und Umweltchemie
Bereich: Fachbereich Ingenieur- und Naturwissenschaften

Raum: Hg/D/1/08
Telefon: +49 3461 46-2012
Fax: +49 3461 46-2192
E-Mail funktional:
E-Mail pers?nlich:

Sprechzeiten:

jederzeit nach Vereinbarung

Homepage:

/kaluderovic

Beauftragter für Internationales
Bereich: -
E-Mail pers?nlich:

T?tigkeitsbereiche

LEHRGEBIETE

  • Anorganische Chemie
  • Biologische Chemie
  • Biotechnologie
  • ?kologische Stoffwandlungsprozesse


FORSCHUNGSBEREICHE

  • Koordinationschemie
  • Bioanorganische Chemie
  • Bioorganische Chemie
  • Bionanochemie

Publikationen

Ausgew?hlte Publikationen und Referenzen

Publikationen
ORCID iD????????? Researchgate-Profil ? ? ? ? ?? ? ? ? ? ? Google Scholar


Ausgew?hlte Publikationen

  • Eichhorn, T., Kolbe, F., Mi?i?, S., Dimi?, D., Morgan, I., Saoud, M., Milenkovi?, D., Markovi?, Z., Rüffer, T., Dimitri? Markovi?, J., Kalu?erovi?, G.N. (2023): Synthesis, Crystallographic Structure, Theoretical Analysis, Molecular Docking Studies, and Biological Activity Evaluation of Binuclear Ru (II)-1-Naphthylhydrazine Complex, Int. J. Mol. Sci., 24, 689.
  • Predarska, I., Saoud, M., Dra?a, D., Morgan, I., Komazec, T., Eichhorn, T., Mihajlovi?, E., Dun?erovi?, D., Mijatovi?, S., Maksimovi?-Ivani?, D., Hey-Hawkins, E., Kalu?erovi?, G.N. (2022): Mesoporous Silica Nanoparticles Enhance the Anticancer Efficacy of Platinum (IV)-Phenolate Conjugates in Breast Cancer Cell Lines, Nanomaterials, 12, 3767.
  • Kne?evi?, N.?., Ili?, N., Kalu?erovi?, G.N. (2022): Mesoporous Silica Nanoparticles for pH-Responsive Delivery of Iridium Metallotherapeutics and Treatment of Glioblastoma Multiforme, Inorganics 10, 250.
  • Bensing, C., Moji?, M., Bulatovi?, M., Edeler, D., Pérez-Quintanilla, D., Gómez-Ruiz, S., Maksimovi?-Ivani?, D., Mijatovi?, S., Kalu?erovi?, G.N. (2022): Effect of chain length on the cytotoxic activity of (alkyl-ω-ol) triphenyltin (IV) loaded into SBA-15 nanostructured silica and in vivo study of SBA-15~Cl| Ph3Sn(CH2)8OH, Biomat. Adv. 140, 213054.
  • Dra?a, D., Edeler, D., Saoud, M., Doj?inovi?, B.,? Dun?erovi?, D., ?mura, G., Maksimovi?-Ivani?, D., Mijatovi?, S., Kalu?erovi?, G.N. (2021): Antitumor potential of cisplatin loaded into SBA-15 mesoporous silica nanoparticles against B16F1 melanoma cells: in vitro and in vivo studies, J. Inorg. Biochem. 217, 111383
  • Arlt, S., Petkovi?, V., Ludwig, G., Eichhorn, T., Lang, H., Rüffer, T., Mijatovi?, S., Maksimovi?-Ivani?, D., Kalu?erovi?, G.N. (2021): Arene Ruthenium(II) Complexes Bearing the κ-P or κ-P,κ-S Ph2P(CH2)3SPh Ligand. Molecules 26, 1860.
  • J?nicke, P., Lennicke, C., Meister, A., Seliger, B., Wessjohanna, L.A., Kalu?erovi?, G.N. (2021): Fluorescent spherical mesoporous silica nanoparticles loaded with emodin: Synthesis, cellular uptake and anticancer activity, Mat. Sci. Eng. C 119, 111619
  • Smolko, L., Smolková, R., Samo?ová, E., Morgan, I., Saoud, M., Kalu?erovi?, G.N. (2020): Two isostructural Co(II) flufenamato and niflumato complexes with bathocuproine: analogues with a different cytotoxic activity, J. Inorg. Biochem. 210, 111160.
  • Edeler, D., Dra?a, D., Petkovi?, V., Natalio, F., Maksimovi?-Ivani?, D., Mijatovi?, S., Schmidt, H., Kalu?erovi?, G.N. (2019):? Impact of the mesoporous silica SBA-15 functionalization on the mode of action of Ph3Sn(CH2)6OH,? Mat. Sci. Eng. C 100, 315-322.
  • Edeler D, Arlt S, Petkovi? V, Ludwig G, Dra?a D, Maksimovi?-Ivani? D, Mijatovi? S, Kalu?erovi? GN. (2018), Drug delivery system for emodin based on mesoporous silica SBA-15 mesoporous silica: Preparation, characterization and in vitro study, J Inorg Biochem. 180, 155–162.
  • Krajnovi? T., Maksimovi?-Ivani? D., Mijatovi? S., Dra?a D., Wolf K., Edeler D., Wessjohann L.A., Kalu?erovi? G.N. (2018), Drug Delivery System for Emodin Based on Mesoporous Silica SBA-15, Nanomaterials 8, pii: E322
  • Hübner, D., Kalu?erovi?, M.R., Gómez-Ruiz, S. and Kalu?erovi?, G.N. (2017), Anionic chlorido(triphenyl)tin(IV) bearing N-phthaloylglycinato or 1,2,4-benzenetricarboxylato 1,2-anhydride ligands: potential cytotoxic and apoptosis-inducing agents against several types of cancer, Chem. Biol. Drug Des. 89, 628–633.
  • Kalu?erovi?, G.N., Abbas, M., Kautz, H.C., Wadaan, M.A.M., Lennicke, C., Seliger, B. and Wessjohann, L.A. (2017), Methionine and seleno-methionine type peptide and peptoid building blocks synthesized by five-component five-center reactions, Chem. Commun. 53, 3777–3780.
  • Ludwig, G., Moji?, M., Bulatovi?, M.Z., Mijatovi?, S., Maksimovi?-Ivani?, D., Steinborn, D. and Kalu?erovi?, G.N. (2016). Biological Potential of Halfsandwich Ruthenium(II) and Iridium(III) Complexes. Anticancer Agents Med Chem. 16, 1455–1460.
  • Bensing, C., Moji?, M., Gómez-Ruiz, S., Carralero, S., Doj?inovi?, B., Maksimovi?-Ivani?, D., Mijatovi?, S. and Kalu?erovi? G.N. (2016): Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph3Sn(CH2)3OH against A2780 ovarian carcinoma cell line, Dalton Trans. 45, 18984–18993.
  • Edeler, D., Kalu?erovi?, M.R., Doj?inovi?, B., Schmidt, H. and Kalu?erovi? G.N. (2016): SBA-15 mesoporous silica particles loaded with cisplatin induce senescence in B16F10 cells, RSC Advances. 6, 111031–111040.
  • Kalu?erovi?, G. N., Krajnovi?, T., Momcilovic, M., Stosic-Grujicic, S., Mijatovi?, S., Maksimovi?-Ivani?, D., Hey-Hawkins, E. (2015). Ruthenium(II) p-cymene complex bearing 2,2’-dipyridylamine targets caspase 3 deficient MCF-7 breast cancer cells without disruption of antitumor immune response, J. Inorg. Biochem. 153, 315–321.
  • Bulatovi?, M. Z., Maksimovi?-Ivani?, D., Bensing, C., Gómez-Ruiz, S., Steinborn, D., Schmidt, H., Moji?, M., Kora?, A., Goli?, I., Pérez-Quintanilla, D., Mom?ilovi?, M., Mijatovi?, S. and Kalu?erovi?, G. N. (2014). Organotin(IV)-Loaded Mesoporous Silica as a Biocompatible Strategy in Cancer Treatment, Angew. Chem. Int. Ed. 53, 5982–5987; Angew. Chem. 126, 6092–6097.
  • Panteli?, N., Zmejkovski, B.B., Trifunovi?-Macedoljan, J., Savi?, A., Stankovi?, D., Damjanovi?, A., Jurani?, Z., Kalu?erovi?, G. N. and Sabo, T. J. (2013). Gold(III) complexes with esters of cyclohexyl-functionalized ethylenediamine-N,N'-diacetate, J. Inorg. Biochem. 128C, 146–153.
  • Ludwig, G., Mijatovi?, S., Ran?elovi?, I., Bulatovi?, M., Miljkovi?, D., Maksimovi?-Ivani?, D., Korb, M., Lang, H., Steinborn, D. and Kalu?erovi?, G. N. (2013). Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph2PCH2S(O)xPh (x = 0–2) ligands, Europ. J. Med. Chem. 69C, 216–222.
  • Maksimovi?-Ivani?, D., Mijatovi?, S., Mirkov, I, Sto?i?-Gruji?i?, S.D., Miljkovi?, D., Sabo, T.J., Trajkovi?, V. and Kalu?erovi?, G.N. (2012). Melanoma tumor inhibition by tetrachlorido(O,O’-dibutyl-ethylenediamine-N,N’-di-3-propionate)platinum(IV) complex: in vitro and in vivo investigations, Metallomics 4, 1155–1159.
  • Sanchez-Munoz, S., Gómez-Ruiz, S., Perez-Quintanilla, D., Morante-Zarcero, S., Sierra, I., Prashar, S., Paschke, R. and Kalu?erovi?, G.N. (2012). Preliminary study of the anticancer applications of mesoporous materials functionalized with the natural product betulinic acid; ChemMedChem, 7, 670–679.
  • Kalu?erovi?, G.N., Dietrich, A., Kommera, H., Kuntsche, J., M?der, K., Mueller, T. and Paschke, R. (2012). Liposomes as vehicles for water insoluble platinum-based potential drug: 2-(4-(tetrahydro-2H-pyran-2-yloxy)-undecyl)propane-1,3-diamminedichloro-platinum(II), Europ. J. Med. Chem. 54, 567–572.
  • Gómez-Ruiz, S., Ceballos-Torres, J., Prashar, S., Fajardo, M., ?i?ak, ?,. Jurani?, Z. D. and Kalu?erovi?, G. N. (2011). One ligand different metal complexes: Biological studies of titanium(IV), tin(IV) and gallium(III) derivatives with the 2,6-dimethoxypyridine-3-carboxylato ligand, J. Organomet. Chem. 696, 3206–3213.
  • Kalu?erovi?, G. N., Pérez-Quintanilla, D., Sierra, I., Prashar, S., Hierro, I., ?i?ak, ?., Jurani?, Z. D., Fajardo, M. and and Gómez-Ruiz, S. (2010). Study of the influence of the metal complex on the cytotoxic activity of titanocene-functionalized mesoporous materials. J. Mater. Chem. 20, 806–814.
  • Kalu?erovi?, G. N., Pérez-Quintanilla, D., ?i?ak, ?,. Jurani?, Z. D. and Gómez-Ruiz, S (2010). Improvement of cytotoxicity of titanocene-functionalized mesoporous materials by the increase of the titanium content. Dalton Trans. 2597–2608.
  • Kalu?erovi?, G. N., Kommera, H., Hey-Hawkins, E., Paschke, R. and Gómez-Ruiz, S. (2010). Synthesis and biological applications of ionic triphenyltin(IV) chloride carboxylate complexes with exceptionally high cytotoxicity, Metallomics 2, 419–428.
  • Pérez-Quintanilla, D., Gómez-Ruiz, S., ?i?ak, ?,. Sierra, I., Prashar, S., Hierro, I. Fajardo, M., Jurani?, Z. D. and Kalu?erovi?, G. N. (2009). A new generation of anticancer drugs. Mesoporous materials modified with titanocene complexes. Chem. – Europ. J. 22, 5588–5597.
  • Kalu?erovi?, G. N., Kommera, H., Schwieger, S., Schmidt, H., Paethanom, A., Kunze, M., Paschke, R. and Steinborn, D. (2009). Preparation, DFT calculations and antitumoral investigations of some platinum(IV) complexes with O,O’-dialkyl-ethylenediamine-N,N’-di-3-propanoate (R2eddp) ligands, Dalton Trans. 10720–10726.


Reviews

  • Kalu?erovi?, G. N., Paschke, R. (2011). Anticancer metallotherapeutics in preclinical Development, Curr. Med. Chem. 18, 4738–4752.
  • Gómez-Ruiz, S., Maksimovi?-Ivani?, D., Mijatovi?, S., Kalu?erovi?, G. N. (2012). On the discovery, mechanism and use of cisplatin and metallocenes in anticancer chemotherapy, Bioinorg. Chem. Appl. Article ID 140284, 1–14.
  • Kne?evi?, N. ?., Kalu?erovi?, G. N. (2017). Silicon-based nanotheranostics, Nanoscale 9, 12821–12829.
  • Mijatovi? S., Bramanti A., Nicoletti, F., Faragone, P., Kalu?erovi?, G. N., Maksimovi?-Ivani?, D. (2018). Naturally occuring compounds in differentiation based therapy of cancer, Biotechnol. Adv. 36, 1622–1632.
  • Zmejkovski, B.B., Panteli?, N.?., Kalu?erovi?, G.N. (2022): Palladium (II) complexes: Structure, development and cytotoxicity from cisplatin analogues to chelating ligands with N stereocenters, Inorg. Chim. Acta 120797.


Buchkapitel

  • Kalu?erovi?, G. N., Schmidt, H., Steinborn, D., Sabo, T. J. (2008). Inorganic Biochemistry: Research Progress. In J. G. Hughes, A. J. Robinson, (Ed.), From synthesis to antitumoral activity of platinum(II) and platinum(IV) complexes with bis(carboxyalkylamino)ethane and -propane ligands (S. 305–326). NY: Nova Science Publishers, Inc. Hauppauge. ISBN: 978-1-60456-708-3.
  • Wessjohann, L. A., Kalu?erovi?, G. N., Neves Filho, R. A. W. et al. (2013). Science of Synthesis: Multicomponent Reactions 1. In T. J. J. Müller (Ed.), Further Components Carboxylic Acid and Amine (Ugi Reaction) (S. 415–502). Stuttgart: Georg Thieme Verlag KG. ISBN: 9783131728616.
  • Wessjohann, L. A., Schreckenbach, H. F., Kalu?erovi?, G. N. (2015). Science of Synthesis: Biocatalysis in Organic Synthesis 2. In K. Faber, W.-D. Fessner, N. J. Turner, N. J. (Eds.), Enzymatic C-Alkylation of Aromatic Compounds (S. 177–211). Stuttgart: Georg Thieme Verlag KG. ISBN: 9783131741417.

Lebenslauf

1994-1999 Chemiestudium, Fakult?t für Chemie, Universit?t Belgrad, Belgrad, Jugoslawien

2002 Magister, Fakult?t für Chemie, Universit?t Belgrad, Belgrad, Serbien und

Montenegro
?Synthese und Charakterisierung gemischter Cobalt(III)- und Platin(IV)-Komplexe mit dem Ethylendiamin-N,N‘-di-3-propionato-Liganden und seinen Derivaten“


2005 Dissertation, Fakult?t für Chemie, Universit?t Belgrad, Belgrad, Serbien undMontenegro

?Synthese, Struktur und in vitro Antitumor-Aktivit?t von Platin(II)- und Platin(IV)-Komplexen mit dem Ethylendiamin-N,N‘-di-3-propionato-Liganden und dessen Estern“


2006–2008 Alexander von Humboldt–Stipendiat bei Prof. Dr. D. Steinborn, Institut für Chemie, Martin-Luther-Universit?t Halle-Wittenberg, Deutschland

05/2014 Habilitation, Naturwissenschaftliche Fakult?t II - Chemie, Physik und Mathematik, Martin-Luther-Universit?t Halle-Wittenberg, Deutschland

“Contribution to the development of anticancer metallotherapeutics – from metal compounds to nanomaterials”


Auszeichnungen
2007 Forschungspreis der Martin-Luckner-Stiftung für Entwicklung neuer Antitumorwirkstoffe
2008 Medaille der Serbischen Chemischen Gesellschaft für herausragende Leistungen und Erfolge in der Wissenschaft im Jahr 2008

2018 Ehrenmitglieder, Leibniz-Forschungsverbund "Wirkstoffe und Biotechnologie"
2020 Forschungspreis bet36体育在线_bet36体育投注¥官网
2021 Doctor Honoris Causa (Dr. h.c.), Universit?t Kragujevac, Serbien
2022 Forschungspreis bet36体育在线_bet36体育投注¥官网

Nach oben